Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) Posts Basic Consolidated EPS Of $-1.4765

0

Northwest Biotherapeutics, Inc. (NASDAQ:NWBO)managed to report annual basic consolidated EPS of $-1.4765, which was for the year ended2015-12-31.The company reported basic consolidated EPS of $-1.4765 for the quarter ended 2015-12-31.

EPS from continuing operations

If you look at the performance of the company’s continuing operations, you see that EPS generated from such operations was {EPS_BASIC_CONT_OPER:1541}} for the year ended 2015-12-31. As for the quarter ended 2015-12-31, continuing operations produced EPS of $-0.1365.

EPS contribution from parent

Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) received of $-1.4765 EPS boost from the parent company for the annual period ended

For the year ended 2015-12-31, the parent of Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) contributed EPS of $-1.4765 to the company’s bottom-line. But for the quarter ended 2015-12-31, EPS boost from the parent was cited as $-1.4765.

What About Basic net EPS

The basic net EPS that Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) reported for the year ended 2015-12-31 stood at $-1.48. For the quarter ended 2015-12-31, the company posted basic net EPS of $-1.48.

What About Consolidated Diluted EPS?

Northwest Biotherapeutics, Inc. (NASDAQ:NWBO)’s consolidated diluted EPS for the year ended 2015-12-31 was reported as $-1.4765. For the quarter ended 2015-12-31 the metric was$-1.4765.

Basic diluted EPS

The company managed to register diluted EPS from continuing operation of at $-1.4765 for the yearended 2015-12-31. But diluted EPS from continuing operations for the quarter ended 2015-12-31 came in at $-1.4765.

Net diluted EPS

Net diluted EPS posted by Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) for the year ended 2015-12-31 was $-1.48. On quarterly basis, net diluted EPS for the quarter ended 2015-12-31 was reported as $-1.48.

What portion of diluted EPS came from parent?

For the annual period ended 2015-12-31, the parent company of Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) said that it parent company boosted its diluted EPS by$-1.4765 in the year ended 2015-12-31. For the quarter ended 2015-12-31, the parent company’s contribution to diluted EPS was $-1.4765.

The company reported net basic EPS of $-1.4288 for the year ended 2015-12-31 and net basic EPS of $-1.4288 for the quarter ended 2015-12-31.

The number of Northwest Biotherapeutics, Inc. (NASDAQ:NWBO)’s basic shares outstanding at the end of the annual period ended 2015-12-31 was 32.865. That compares with 32.865 basic shares outstanding for the quarter ended 2015-12-31.

Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) had 32.865 diluted shares outstanding at the end of the annual period ended 2015-12-31. But for the quarter ended 2015-12-31, diluted outstanding shares were 32.865.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 65 times, 1 visits today)